High-dose intra-arterial cisplatin boost with hyperfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck

Journal of Clinical Oncology

Volumn 19, Issue 14, 2001, Pages 3333-3339

  Regine, W F ^a   Valentino, J ^a   Arnold, S M ^a   Haydon, R C ^a   Sloan, D ^a   Kenady, D ^a   Strottmann, J ^a   Pulmano, C ^a   Mohiuddin, M ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL; PACLITAXEL;

ANXIETY; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CAROTID ARTERY OBSTRUCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; HEAD AND NECK CANCER; HUMAN; INFECTION; NAUSEA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; RADIATION RESPONSE; SKIN DISEASE; SQUAMOUS CELL CARCINOMA; VOMITING;

EID: 0035879299     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.14.3333     Document Type: Article

References (34)

1. Radiotherapy and concurrent chemotherapy for the treatment of locally advanced head and neck squamous cell carcinoma
2. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003
3. Adjuvant chemotherapy for head and neck cancer
4. Head and neck cancer
5. Therapeutic potentiation in a mouse mammary tumor and an intracerebral rat brain tumor by combined cisdicholorodiamine-platinum (II) and radiation
6. Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck: An RTOG study
7. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099
8. Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer
9. Chemoradiotherapy for organ preservation in oral and pharyngeal carcinoma
10. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer
11. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial
12. Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: Impact on the natural history of the disease
13. Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma
14. Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: A phase I/II trial
15. Phase II/II study of the CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynx
16. Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: Improved disease control and survival
17. Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer
18. A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer
19. Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: The Memphis experience
20. High-dose intra-arterial cisplatin and concurrent hyperfractionated radiation therapy in patients with locally advanced primary squamous cell carcinoma of the head and neck: Report of a phase 11 study
21. Nonparametric estimation from incomplete observations
22. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy
23. Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck: The University of Florida experience
24. Accelerated fractionation vs hyperfractionation: Rationales for several treatments per day
25. Accelerated fractionation in the radiation treatment of head and neck cancer: A critical comparison of different strategies
26. The hazard of accelerated tumor clonogen repopulation during radiotherapy
27. Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: Preliminary report of radiation therapy oncology group protocol 83-13
28. Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: Long-term follow-up results of RTOG 83-13
29. Effect of sodium thiosulfate on cisdichlorodiammineplatinum (II) toxicity and antitumor activity in L1210 leukemia
30. Pharmacokinetic principles of regional chemotherapy
31. Phase I/II trial of radiation with chemotherapy boost for advanced squamous cell carcinomas of the head and neck: Toxicities and responses
32. The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck